FDA Panel Supports Removing Warnings on Menopause Hormone Therapy

TL;DR
An FDA expert panel recommended removing the black box warning on menopausal hormone therapies, citing potential benefits and questioning the overemphasis on risks, which could lead to increased use of these treatments for menopausal women.
- FDA panel backs menopausal hormone therapy Axios
- F.D.A. Panelists Call for Removal of Warnings on Menopause Treatments The New York Times
- FDA chief: HRT warning among ‘greatest mistakes of modern medicine’ NewsNation
- FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women fda.gov
- US could scrap health warnings on HRT The Telegraph
Want the full story? Read the original reporting
Read on Axios